AU5179800A - Mycolactone and related compounds, compositions and methods of use - Google Patents
Mycolactone and related compounds, compositions and methods of useInfo
- Publication number
- AU5179800A AU5179800A AU51798/00A AU5179800A AU5179800A AU 5179800 A AU5179800 A AU 5179800A AU 51798/00 A AU51798/00 A AU 51798/00A AU 5179800 A AU5179800 A AU 5179800A AU 5179800 A AU5179800 A AU 5179800A
- Authority
- AU
- Australia
- Prior art keywords
- mycolactone
- compositions
- methods
- related compounds
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- WKTLNJXZVDLRTJ-QRRXZRELSA-N Mycolactone Chemical compound C[C@@H](O)C[C@@H](O)[C@H](C)\C=C(/C)C[C@H](C)[C@H]1C\C=C(C)\C[C@H](C)[C@@H](OC(=O)\C=C\C(\C)=C\C(\C)=C\C=C\C(\C)=C\[C@H](O)[C@@H](O)C[C@H](C)O)CCCC(=O)O1 WKTLNJXZVDLRTJ-QRRXZRELSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229930185122 mycolactone Natural products 0.000 title 1
- WKTLNJXZVDLRTJ-PPVVEJQLSA-N mycolactone A Natural products CC(O)CC(O)C(C)C=C(/C)CC(C)C1CC=C(/C)CC(C)C(CCCC(=O)O1)OC(=O)C=CC(=C/C(=C/C=C/C(=C/C(O)C(O)CC(C)O)/C)/C)C WKTLNJXZVDLRTJ-PPVVEJQLSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13736799P | 1999-06-03 | 1999-06-03 | |
US60137367 | 1999-06-03 | ||
PCT/US2000/015428 WO2000075126A1 (en) | 1999-06-03 | 2000-06-02 | Mycolactone and related compounds, compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5179800A true AU5179800A (en) | 2000-12-28 |
Family
ID=22477090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU51798/00A Abandoned AU5179800A (en) | 1999-06-03 | 2000-06-02 | Mycolactone and related compounds, compositions and methods of use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1192147A1 (en) |
JP (1) | JP2003501423A (en) |
AU (1) | AU5179800A (en) |
CA (1) | CA2376010A1 (en) |
WO (1) | WO2000075126A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002041888A1 (en) * | 2000-11-23 | 2002-05-30 | Biogenia Co., Ltd. | Anticancer agent comprising mycolactone |
TWI311558B (en) * | 2001-02-01 | 2009-07-01 | Mercian Corporatio | Novel physiologically active substance |
TWI334866B (en) | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
US7576204B2 (en) | 2002-07-31 | 2009-08-18 | Mercian Corporation | Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same |
RU2330069C2 (en) | 2002-11-29 | 2008-07-27 | Мершан Корпорейшн | Method of obtaining macrolide compound and streptomyces sp, mortierella sp and micromonosporaceae strains |
WO2005047509A2 (en) * | 2003-11-14 | 2005-05-26 | University Of Tennessee Research Foundation | The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
WO2006000923A2 (en) * | 2004-06-03 | 2006-01-05 | Novimmune Sa | Macrolide compositions as therapeutic agent |
BRPI0805837A2 (en) | 2007-01-29 | 2011-08-30 | Eisai R&D Man Co Ltd | solid form of a compound, method for preparation of crystals, pharmaceutical composition, method of treating cancer, and use of solid compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264430A (en) * | 1997-05-02 | 2000-08-23 | 研究技术集成责任有限公司 | Betaines as adjuvants to susceptibility testing and antimicrobial therapy |
-
2000
- 2000-06-02 AU AU51798/00A patent/AU5179800A/en not_active Abandoned
- 2000-06-02 CA CA002376010A patent/CA2376010A1/en not_active Abandoned
- 2000-06-02 JP JP2001502409A patent/JP2003501423A/en active Pending
- 2000-06-02 EP EP00936488A patent/EP1192147A1/en not_active Ceased
- 2000-06-02 WO PCT/US2000/015428 patent/WO2000075126A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000075126A1 (en) | 2000-12-14 |
EP1192147A1 (en) | 2002-04-03 |
JP2003501423A (en) | 2003-01-14 |
CA2376010A1 (en) | 2000-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPQ419099A0 (en) | Novel compositions and methods | |
AU2609901A (en) | Antimicrobial compositions and methods of use | |
AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
AU3958100A (en) | New compounds, their preparation and use | |
AU3958200A (en) | New compounds, their preparation and use | |
AU2268301A (en) | Novel urea compounds, compositions and methods of use and preparation | |
AU3867400A (en) | Methods of using bioelastomers | |
AU7490900A (en) | Chemical compounds and compositions and their use as cathepsin s inhibitors | |
AU3957900A (en) | New compounds, their preparation and use | |
GB9903216D0 (en) | Preservative compounds,compositions and methods of making and using the same | |
AU4318000A (en) | Agarobiose-containing composition | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU1290501A (en) | Composition | |
AU1403501A (en) | Novel composition and use | |
AU5029700A (en) | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | |
AU4996100A (en) | (s,r) formoterol methods and compositions | |
AU1152601A (en) | Compositions and their use | |
AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
AU5176299A (en) | Compound, composition and use | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU4450100A (en) | 225Ac-heha and related compounds, methods of synthesis and methods of use | |
AU4839100A (en) | Methods of using and compositions comprising n-desmethylzolpidem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |